Authors
Latest:
Everyone Loves e-Prescribing! Right?Electronic prescribing is rapidly gaining support from a diverse array of healthcare organizations, government agencies, and technology corporations.
Latest:
The Core of Compassion in Physician-Assisted SuicideThe practice has only reached a handful of states in 25 years of proposal. What drives the arguments for and against it?
Latest:
Large-scale clinical epidemiology of stable angina in women and menWe performed a whole-country study using linked health care records in Finland and showed that stable angina as the initial symptomatic manifestation of coronary disease occurs as frequently in women as it does in men. Among easily recognized subgroups, the absolute rates of prognostic outcomes were similarly high in women and men.
Latest:
Barriers Remain for Better Hepatitis C Virus CareTreatment initiation was lower among Medicaid and private health insurance recipients aged 18-29 years, compared with patients aged 50-59 years.
Latest:
The Relative Unimportance of Diagnosis in PsychiatryShrinkRap guest blogger Dr. Mitchell Newmark looks at the pitfalls of diagnosis in psychiatry.
Latest:
Nurses Are the Center of COVID-19 Crisis Communication. Is Tech Helping?A deeper look at how nurses are affected during the current health pandemic.
Latest:
Transcatheter occlusion of the left atrial appendage to prevent stroke in atrial fibrillationWe conducted 2 feasibility studies to assess the performance and safety of the percutaneous left atrial appendage (LAA) transcatheter occlusion system for the prevention of stroke in high-risk patients with nonrheumatic atrial fibrillation. Results showed that percutaneous LAA occlusion can be performed using the device at acceptable risk. This procedure may be particularly useful for patients at increased risk of ischemic stroke with a contraindication to anticoagulation therapy.
Latest:
Advances in the Treatment of Diabetic Kidney DiseaseOn this episode of MEDcast, Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC are joined by Dr George Bakris to discuss the latest advances in treatments and comprehensive care for patients with diabetes and chronic kidney disease.
Latest:
Managing Oral Mucositis in Patients With CancerOral mucositis is a costly consequence of cancer therapy that can impede the efficacy of anticancer therapy. Simple preventive measures can greatly improve the patient�s outcome and quality of life.
Latest:
Concerns about Pain Guidelines: When Strong Claims Follow from Weak EvidenceThe development of clinical medical-practice guidelines is a difficult and arduous process. Experts in various disciplines volunteer many hours of their time for medical research reviews and analyses and meetings with fellow guidelines-panel members, and painstakingly writing and reviewing the final report. However, there are many concerns about the quality of medical research serving as a basis for those guidelines.
Latest:
Serial biomarker measurements in chronic heart failureCardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) have been used to estimate prognosis in heart failure. However, most studies have evaluated decompensated patients using single measurements. To determine the value of serial measurements, we evaluated 190 stable chronic heart failure patients every 3 months during 2 years.
Latest:
Health Reform in the Obama Era: The Case for Heart and Stroke ResearchSeveral beneficial goals should be considered as the nation contemplates health reform: (1) increase congressional awareness of the importance of heart and stroke research; (2) increase public awareness of the importance of heart and stroke research; and (3) increase funding for federal heart and stroke research.
Latest:
Taking the Guesswork Out of Concussion TestsNew technology uses the eyes to assess brain injuries in student athletes.
Latest:
The A-Z Business WireThe latest business and financial biotech news. In this issue: 1) Adherex Buys Back GSK's Rights to Failed Cancer Drug 2) Archemix and Merck Partner on Aptamer-Based Cancer Therapeutics 3) CEL-SCI Receives $15 Million Commitment for Cancer Drug Manufacturing Facility 4) Genentech and Seattle Genetics Ink Deal Potentially Worth $860 Million 5) Dana-Farber Cancer Institute Launches $1-Billion Campaign
Latest:
Are Butter and Full Fat Foods Safe?This was a systemic review and meta-analysis of randomized control trials regarding the relationship between dietary fat consumption, serum cholesterol levels, and subsequent coronary heart disease development.
Latest:
Multivessel CAD in ACS patients: Four important implicationsThe article by Schwartzman and Brener (page 33) has 4 important implications for the treatment of acute coronary syndrome (ACS) patients who are found to have multivessel coronary artery disease (CAD) during diagnostic coronary angiography.
